E-Scopics Announces New FDA Clearance for Hepatoscope®
E-Scopics has received FDA clearance for its Hepatoscope®, which now includes advanced elastography imaging features and improved compatibility for managing complications related to liver disease. The company will present these innovations at DDW 2026 in Chicago.
AIX-EN-PROVENCE, France & ST. LOUIS–(BUSINESS WIRE)–E-Scopics Announces New FDA Clearance for Hepatoscope® Expanding management of Liver disease complications. Company to exhibit at DDW 2026 Chicago.